Sotera Health

Sotera Health Co. provides mission-critical sterilization, lab testing and advisory services to the medical device and pharmaceutical industries. It also provides end-to-end sterilization as well as microbiological and analytical lab testing and advisory services to help ensure that medical, pharmaceutical and food products are safe for healthcare practitioners, patients and consumers. The firm operates through the following businesses: Sterigenics, Nordion, and Nelson Labs. The Sterigenics business provides outsourced terminal sterilization and irradiation services for the medical device, pharmaceutical, food safety and advanced applications markets by using following technologies: gamma irradiation, EO processing and E-beam irradiation. The Nordion business provides Co-60 and gamma irradiators, which are the key components to the gamma sterilization process. The Nelson Labs business provides outsourced microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries. The company was founded in 1978 and is headquartered in Broadview Heights, OH.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Sotera Health reports solid Q4 growth, cautious outlook for 2023

Sotera Health delivered growth in Q4 2022, closed a major litigation settlement, and outlined a cautious outlook for 2023. Strategic investments in EO enhancements and pharma growth signal long-term vision, while challenges in revenue and adjusted EPS are acknowledged. Overall, the company remains optimistic about future growth prospects.

Sotera Health reports Q1 revenue decline, eyes growth opportunities

Sotera Health faced revenue and EBITDA declines in Q1 2023 but remains optimistic about future growth prospects.
The company is addressing challenges in inflation, labor, and supply chains while focusing on operational improvements.
Opportunities for revenue growth exist through Nordion volumes, facility enhancements, and regulatory compliance efforts.
Overall, Sotera Health's performance reflects a mix of challenges, strengths, and opportunities for strategic advancement.

Sotera Health releases settlement funds, faces revenue declines in Q2

Sotera Health navigated challenges in Q2 2023 with declines in revenues and adjusted EBITDA but showcased strengths in strategic planning and operational efficiency.
The company's outlook remains positive, with opportunities for growth through capacity expansions and improved volumes in the second half of the year.
Addressing challenges in revenue performance and customer inventory levels will be crucial for sustaining growth and investor confidence.
Proactive measures and transparent communication underscore Sotera Health's commitment to navigating market uncertainties and driving long-term success.

Sotera Health reports revenue growth amidst challenges and opportunities

Sotera Health (SHC) delivered a mixed performance in Q3 2023 with revenue growth, margin improvement, and operational challenges.
The company maintains a strong liquidity position and is actively managing its financial metrics to drive long-term growth.
While facing challenges from external factors, Sotera Health (SHC) has opportunities to enhance efficiency and capitalize on growth prospects.

Sotera Health (SHC) posts robust Q4 results, eyes 2024 growth

Sotera Health (SHC) delivered strong financial performance in Q4 2023 and full year.
Operational achievements and resolved litigation bolstered the company's position.
Challenges include potential impact on revenue growth from Nordion contracts.
Optimistic outlook for 2024 with a focus on customer value and safety.

Sotera Health (SHC) reports robust Q1 performance and growth outlook

Sotera Health (SHC) delivered strong Q1 2024 results, reaffirming growth outlook and showcasing financial resilience.
Management's confidence in defense against lawsuits and compliance with regulations, alongside strategic investments, underpin the company's stability and growth potential.
With a focus on operational efficiency, capacity expansions, and investor engagement, Sotera Health (SHC) is poised for sustainable growth and value creation.

Sotera Health posts robust Q2 results, eyes efficiency and growth

Sotera Health delivered strong financial results in Q2 2024, supported by revenue growth and operational improvements across key segments.
Despite challenges such as FX headwinds and macroeconomic uncertainties, the company's solid liquidity position and debt refinancing strengthen its financial foundation.
Opportunities lie in optimizing cash flow, managing capital expenditures, and leveraging new board expertise for sustained growth and value creation.

Sotera Health reports robust Q3 growth, affirms 2024 outlook

Sotera Health's Q3 2024 performance reflects strong revenue and EBITDA growth across key business segments, underlining operational efficiency and market demand.
While facing challenges in regulatory compliance and market dynamics, the company's diverse strengths in critical sectors and upcoming Investor Day signal resilience and strategic focus.
By addressing challenges, leveraging opportunities, and maintaining growth momentum, Sotera Health aims to sustain its positive performance trajectory and investor appeal in the competitive landscape.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Sotera Health Company (NASDAQ:SHC ) Q3 2023 Earnings Conference Call November 1, 2023 9:00 AM ET Corporate Participants Jason Peterson - Vice President and Treasurer Michael Petras - Chairman and Chief Executive Officer Jonathan Lyons - Senior Vice President and Chief Financial Officer Conference Call Participants Sean Dodge - RBC Capital Markets Patrick Donnelly - Citi Michael Polark - Wolfe Research Casey Woodring - JPMorgan Operator Good morning and welcome to the Sotera Health Third Quarter 2023 Conference Call. All participants will be in a listen-only mode.

Sotera Health Company (SHC) Q3 2023 Earnings Call Transcript

CLEVELAND, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced financial results for the three and nine months ended September 30, 2023.

Sotera Health Reports Third-Quarter and Year-to-Date 2023 Results

CLEVELAND, Oct. 18, 2023 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, today announced its plans to release its financial results for the third-quarter ended September 30, 2023 before the market opens on Wednesday, November 1, 2023. Following the release, management will hold a conference call at 9:00 a.m. Eastern Time to discuss the Company's operating highlights and financial results.

Sotera Health Announces Third-Quarter 2023 Earnings Release Date

Sotera Health stock has declined 22% in the past six months due to concerns over guidance, rising interest expense, and fears about slower medical device sales. However, these concerns are overblown as Sotera's Sterigenics sterilization business continues to show strong growth and profitability. Sotera benefits from overall growth in the medical device and pharmaceutical industry and is not overly exposed to any particular category.

Sotera Health: A Great Business At A Discount

NEW YORK--(BUSINESS WIRE)-- #A--Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Sotera Health Co. (NASDAQ: SHC) on behalf of long-term stockholders following a class action complaint that was filed against Sotera on January 24, 2023 with a Class Period pursuant to the November 20, 2020 IPO; pursuant to the March 18, 2021 SPO; and/or between November 20, 2020 and September 19, 2022. Our investigation concerns whether the.

SOTERA ALERT: Bragar Eagel & Squire, P.C. is Investigating Sotera Health Co. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Sotera Health Company (NASDAQ:SHC ) Q2 2023 Earnings Conference Call August 3, 2023 9:00 AM ET Corporate Participants Jason Peterson - Vice President and Treasurer Michael Petras - Chairman and Chief Executive Officer Jonathan Lyons - Chief Financial Officer Conference Call Participants Sean Dodge - RBC Capital David Windley - Jefferies Luke Sergott - Barclays Casey Woodring - JPMorgan Matthew Mishan - KeyBanc Michael Polark - Wolfe Research Operator Good morning, and welcome to the Sotera Health Second Quarter 2023 Conference Call. All participants will be in listen-only mode.

Sotera Health Company (SHC) Q2 2023 Earnings Call Transcript

Although the revenue and EPS for Sotera Health Company (SHC) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Compared to Estimates, Sotera Health Company (SHC) Q2 Earnings: A Look at Key Metrics

Sotera Health Company (SHC) came out with quarterly earnings of $0.21 per share, beating the Zacks Consensus Estimate of $0.18 per share. This compares to earnings of $0.27 per share a year ago.

Sotera Health Company (SHC) Tops Q2 Earnings Estimates

CLEVELAND, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced financial results for the three and six months ended June 30, 2023.

Sotera Health Reports Second-Quarter and First-Half 2023 Results

Tesla

Allegiant Travel Company

Arlo Technologies Inc

eXp World Holdings Inc

NeoGenomics

PROG Holdings

B. Riley Financial

World Acceptance

What's been one of the easiest ways to make big money on stocks this year? Pick up stocks in and out of the S&P 500 others left for dead.

Investors Make A Bundle On 10 Stocks Others Panic Sold (Like Tesla)

CLEVELAND, July 18, 2023 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, today announced its plans to release its financial results for the second-quarter ended June 30, 2023 before the market opens on Thursday, August 3, 2023. Following the release, management will hold a conference call at 9:00 a.m. Eastern Time to discuss the Company's operating highlights and financial results.

Sotera Health Announces Second-Quarter 2023 Earnings Release Date

CLEVELAND, June 26, 2023 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, announced that Jon Lyons has joined the Company, effective today, as Senior Vice President and Chief Financial Officer (“CFO”). Mr. Lyons recently served as Vice President, Corporate FP&A for Owens Corning (NYSE: OC), a nearly $10 billion global building and construction materials leader. Prior to this role, Mr. Lyons was Vice President and Finance leader for Owens Corning's $3.7 billion Insulation business and the company's $2.7 billion Composites business. He was previously also the company's Treasurer. Mr. Lyons has also held several senior leadership roles in treasury, FP&A, investor relations and tax during his 8-year career at Cardinal Health (NYSE: CAH) after beginning his career in public accounting.

Sotera Health Announces Jon Lyons as New Senior Vice President and Chief Financial Officer

Sotera Health's stock saw a 20% increase after the company proceeded with settlements related to its Illinois plant. The financial impact of the claims is expected to be limited, with no additional charges beyond what has already been incurred from Q4 FY'22. Despite this, at 22x forward earnings, there are more selective opportunities elsewhere with event-driven alpha.

Sotera Health: No Economic Change After Sterigenics Settlement, Rate Hold

Sotera Health Company (SHC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Strength Seen in Sotera Health Company (SHC): Can Its 17.3% Jump Turn into More Strength?

The class action lawsuit was against Sterigenics, a subsidiary of Sotera. Sotera said it expects annual revenue between $1.055 billion and $1.09 billion.

Why Shares of Sotera Health Jumped Thursday

Overstock.com

The Nasdaq Composite has consistently outpaced other indexes in 2023. Overstock.com won an auction for certain assets of Bed Bath & Beyond.

These 2 Nasdaq Stocks Are Jumping by Leaps and Bounds Thursday

One under-the-radar company that's seeing an impressive surge in today's session is Sotera Health (NASDAQ: SHC ). Amid a rally in various Nasdaq stocks today, SHC stock has seen an upward move.

Why Is Sotera Health (SHC) Stock Up 20% Today?

CLEVELAND, June 22, 2023 (GLOBE NEWSWIRE) -- Sotera Health Company (“The Company”) (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, today announced that the opt-in process for the January 2023 settlements of ethylene oxide claims against Sterigenics in the Circuit Court of Cook County, Illinois is complete and Sterigenics has elected to proceed with the settlements. 879 of the 882 claimants eligible to participate in the settlement program have opted in.

Sotera Health Finalizes Settlement of Ethylene Oxide Litigation in Illinois

SAN DIEGO--(BUSINESS WIRE)---- $SHC #SoteraHealthCompany--Sotera Health Company's (SHC) EtO Processing Emitted Massive Toxins and Caused Cancer in People Living in the Communities Near its Facilities.

Sotera Health Company (SHC) Investigation: Robbins LLP is Investigating the Officers and Directors of Sotera Health Company

Nelson Labs' weak 1Q23 performance and uncertain macroeconomic environment raise doubts about its ability to meet expectations and improve margins. Sotera Health's FY23 guidance puts significant pressure on 2H23 performance. The unresolved litigation risk surrounding SHC adds to the uncertainties.

Sotera Health: Still Many Uncertainties With The Stock

CLEVELAND, May 12, 2023 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (NASDAQ: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced that Chairman and CEO Michael B. Petras, Jr. will participate in an open forum discussion at the 2023 RBC Capital Markets Global Healthcare Conference on Tuesday, May 16, 2023 at 4:35 pm Eastern. Sotera Health management will also participate in one-on-one meetings with investors during the conference.

Sotera Health to Present at the 2023 RBC Capital Markets Global Healthcare Conference

Accolade

Bio-Rad Laboratories

Quest Diagnostics

Sangamo Therapeutics

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Top 5 Health Care Stocks That Could Lead To Your Biggest Gains In May - Bio-Rad Laboratories (NYSE:BIO), Accolade (NASDAQ:ACCD)

Sotera Health Company (NASDAQ:SHC ) Q1 2023 Earnings Conference Call May 3, 2023 8:30 AM ET Company Participants Jason Peterson - Vice President and Treasurer Michael Petras - Chairman and Chief Executive Officer Michael Biehl - Interim Chief Financial Officer Conference Call Participants Elizabeth Speyer - Citi Michael Polark - Wolfe Research Sean Dodge - RBC Capital Markets Luke Sergott - Barclays David Windley - Jefferies Casey Woodring - J.P. Morgan Matthew Mishan - KeyBanc Capital Markets Operator Good morning, and welcome to the Sotera Health First Quarter 2023 Conference Call.

Sotera Health Company (SHC) Q1 2023 Earnings Call Transcript

Sotera Health Company (SHC) came out with quarterly earnings of $0.13 per share, missing the Zacks Consensus Estimate of $0.14 per share. This compares to earnings of $0.22 per share a year ago.

Sotera Health Company (SHC) Q1 Earnings and Revenues Lag Estimates

CLEVELAND, May 03, 2023 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced financial results for the three months ended March 31, 2023.

News for Sotera Health Stock (SHC)